161 related articles for article (PubMed ID: 21770714)
1. Evaluation of serum IgG subclass concentrations in myasthenia gravis patients.
Liu Y; Wang W; Li J
Int J Neurosci; 2011 Oct; 121(10):570-4. PubMed ID: 21770714
[TBL] [Abstract][Full Text] [Related]
2. Acetylcholine receptor antibody in myasthenia gravis: predominance of IgG subclasses 1 and 3.
Rødgaard A; Nielsen FC; Djurup R; Somnier F; Gammeltoft S
Clin Exp Immunol; 1987 Jan; 67(1):82-8. PubMed ID: 3621677
[TBL] [Abstract][Full Text] [Related]
3. Ancylostoma duodenale infection: a study of serum immunoglobulin G4 response to the excretory secretory antigen of adult worm.
Mahmoud MS; Abou Gamra MM; Elkhayat MM
J Egypt Soc Parasitol; 2005 Apr; 35(1):1-17. PubMed ID: 15880990
[TBL] [Abstract][Full Text] [Related]
4. IgG subclass distribution of ryanodine receptor autoantibodies in patients with myasthenia gravis and thymoma.
Mygland A; Tysnes OB; Aarli JA; Matre R; Gilhus NE
J Autoimmun; 1993 Aug; 6(4):507-15. PubMed ID: 8216692
[TBL] [Abstract][Full Text] [Related]
5. Immunoglobulin G subclass antibody profiles in Porphyromonas gingivalis-associated aggressive and chronic periodontitis patients.
Takeuchi Y; Aramaki M; Nagasawa T; Umeda M; Oda S; Ishikawa I
Oral Microbiol Immunol; 2006 Oct; 21(5):314-8. PubMed ID: 16922931
[TBL] [Abstract][Full Text] [Related]
6. A triple antibody assay for the quantitation of plasma IgG subclass antibodies to acetylcholine receptors in patients with myasthenia gravis.
Nielsen FC; Rødgaard A; Djurup R; Somnier F; Gammeltoft S
J Immunol Methods; 1985 Nov; 83(2):249-58. PubMed ID: 3902978
[TBL] [Abstract][Full Text] [Related]
7. Non-receptor muscle antibodies in myasthenia gravis are of IgG1 and IgG4 subclasses.
Hofstad H; Gilhus NE; Matre R; Aarli JA
Autoimmunity; 1992; 12(4):271-6. PubMed ID: 1391596
[TBL] [Abstract][Full Text] [Related]
8. The immunoglobulin G subclass distribution of anti-GBM autoantibodies against rHalpha3(IV)NC1 is associated with disease severity.
Zhao J; Yan Y; Cui Z; Yang R; Zhao MH
Hum Immunol; 2009 Jun; 70(6):425-9. PubMed ID: 19364515
[TBL] [Abstract][Full Text] [Related]
9. Sustained response to Rituximab in anti-AChR and anti-MuSK positive Myasthenia Gravis patients.
Illa I; Diaz-Manera J; Rojas-Garcia R; Pradas J; Rey A; Blesa R; Juarez C; Gallardo E
J Neuroimmunol; 2008 Sep; 201-202():90-4. PubMed ID: 18653247
[TBL] [Abstract][Full Text] [Related]
10. Clinical fluctuations in MuSK myasthenia gravis are related to antigen-specific IgG4 instead of IgG1.
Niks EH; van Leeuwen Y; Leite MI; Dekker FW; Wintzen AR; Wirtz PW; Vincent A; van Tol MJ; Jol-van der Zijde CM; Verschuuren JJ
J Neuroimmunol; 2008 Mar; 195(1-2):151-6. PubMed ID: 18384886
[TBL] [Abstract][Full Text] [Related]
11. Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction.
Gomez AM; Van Den Broeck J; Vrolix K; Janssen SP; Lemmens MA; Van Der Esch E; Duimel H; Frederik P; Molenaar PC; Martínez-Martínez P; De Baets MH; Losen M
Autoimmunity; 2010 Aug; 43(5-6):353-70. PubMed ID: 20380584
[TBL] [Abstract][Full Text] [Related]
12. [Determination of human IgG subclass by EIA].
Rinsho Byori; ; . PubMed ID: 1593769
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
